Journey Medical Corp. (DERM)
7.53
-0.38
(-4.80%)
USD |
NASDAQ |
Aug 25, 16:00
7.53
0.00 (0.00%)
After-Hours: 19:45
Journey Medical Debt to Equity Ratio : 0.7953 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.7953 |
| March 31, 2026 | 0.826 |
| December 31, 2025 | 0.7973 |
| September 30, 2025 | 0.9769 |
| June 30, 2025 | 1.313 |
| March 31, 2025 | 1.168 |
| December 31, 2024 | 1.281 |
| September 30, 2024 | 1.928 |
| June 30, 2024 | 2.019 |
| March 31, 2024 | 1.372 |
| December 31, 2023 | 0.8713 |
| September 30, 2023 | 0.1802 |
| Date | Value |
|---|---|
| June 30, 2023 | 2783.80 |
| March 31, 2023 | 3.572 |
| December 31, 2022 | 1.568 |
| September 30, 2022 | 0.9703 |
| June 30, 2022 | 0.6115 |
| March 31, 2022 | 0.5101 |
| December 31, 2021 | 0.2152 |
| September 30, 2021 | -3.514 |
| June 30, 2021 | -29.71 |
| March 31, 2021 | |
| December 31, 2020 | 1.248 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Nektar Therapeutics | 0.1505 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 98.36M |
| Total Liabilities (Quarterly) | 66.24M |
| Shareholders Equity (Quarterly) | 32.11M |
| Current Ratio | 1.590 |
| Net Debt Paydown Yield | -0.04% |